{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:51:01Z","timestamp":1791582661641,"version":"4.3.4"},"reference-count":50,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"abstract":"\n Importance<\/jats:title>\n Attention-deficit\/hyperactivity disorder (ADHD) affects tens to hundreds of millions of adults worldwide, and preliminary evidence suggests it may be associated with increased risk of mild cognitive impairment (MCI) and dementia. However, concerns regarding diagnostic ascertainment and residual confounding remain.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate the association of ADHD with incident cognitive impairment, defined as MCI or dementia, using electronic health record (EHR) diagnoses and genetic liability measured using genome-wide ADHD polygenic risk score (ADHD PRS) in the same individuals.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study used data from the US All of Us Research Program (enrollment May 6, 2018, to October 1, 2023; EHR data from January 4, 1985, to October 1, 2023; mean [SD] follow-up 10.26 [6.75] years). A total of 187\u202f341 participants aged 50 years and older with available EHR and genomic data were included. Data were analyzed from October 2025 to July 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n ADHD diagnosis and ADHD PRS.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Incident MCI or dementia.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Among 187\u202f341 participants (mean [SD] age, 56.41 [7.88] years; 107\u202f266 [57%] female), 3026 (1.6%) had ADHD. Among participants with ADHD, 203 (6.7%) developed cognitive impairment, compared with 6259 (3.4%) among those without ADHD. In adjusted Cox models, ADHD was associated with a more than 4-fold higher hazard of cognitive impairment (hazard ratio [HR], 4.60; 95% CI, 3.99-5.29;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Adjustments for comorbidities, educational attainment, and health care utilization attenuated but did not eliminate the association. Similarly, ADHD PRS was associated with incident cognitive impairment (highest vs lowest quintile: HR, 1.35; 95% CI, 1.25-1.46;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001). Among participants who developed cognitive impairment, comorbid ADHD diagnosis was associated with a nearly 2-fold higher odds of suboptimal mental health (odds ratio [OR], 1.69; 95% CI, 1.18\u20132.39;\n P<\/jats:italic>\n \u2009=\u2009.01), quality of life (OR, 1.66; 95% CI, 1.14-2.39;\n P<\/jats:italic>\n \u2009=\u2009.02), social satisfaction (OR, 2.39; 95% CI, 1.69\u20133.37;\n P<\/jats:italic>\n \u2009&amp;lt;\u2009.001), and 20% higher health care utilization (incidence rate ratio, 1.20; 95% CI, 1.09\u20131.34;\n P<\/jats:italic>\n \u2009=\u2009.003), suggesting greater care burden beyond the elevated incidence risk.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study, convergent clinical and genetic evidence revealed ADHD was associated with a markedly increased risk of late-life cognitive impairment. Among those who develop cognitive impairment, an ADHD diagnosis was associated with worse health outcomes and greater health care utilization, supporting the need for targeted monitoring and integrated care in this population.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamapsychiatry.2026.3165","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:00:40Z","timestamp":1791385240000},"source":"Crossref","is-referenced-by-count":0,"title":["Attention-Deficit\/Hyperactivity Disorder and Late-Life Cognitive Impairment"],"prefix":"10.1001","author":[{"given":"Guilherme","family":"Bauer-Negrini","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas Teixeira","family":"Leffa","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela C. L.","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S.","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza Z.","family":"Lussier","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Tudorascu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[{"name":"Developmental Evidence Synthesis, Prediction, and Implementation Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom"},{"name":"Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom"},{"name":"Hampshire and Isle of Wight Healthcare National Health Service Foundation Trust, Southampton, United Kingdom"},{"name":"Hassenfeld Children\u2019s Hospital at New York University Langone, New York University Child Study Center, New York"},{"name":"DiMePRe-J-Department of Precision and Regenerative Medicine-Jonic Area, University of Bari \u201cAldo Moro,\u201d Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Augusto","family":"Rohde","sequence":"additional","affiliation":[{"name":"ADHD Outpatient Program & Development Psychiatry Program, Hospital de Cl\u00ednicas de Porto Alegre, Porto Alegre, Brazil"},{"name":"National Institute of Developmental Psychiatry & National Center for Innovation and Research in Mental Health, S\u00e3o Paulo, Brazil"},{"name":"Medical Council, Centro Universit\u00e1rio Max Planck (UniMAX), Indaiatuba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke S. G.","family":"Molina","sequence":"additional","affiliation":[{"name":"Departments of Psychiatry, Psychology, Pediatrics, Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania"},{"name":"Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"yoi260047r1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-031-11802-9","article-title":"ADHD in children and adults: diagnosis and prognosis.","volume":"57","author":"Leffa","year":"2022","journal-title":"Curr Top Behav Neurosci"},{"key":"yoi260047r2","doi-asserted-by":"publisher","first-page":"04009","DOI":"10.7189\/jogh.11.04009","article-title":"The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis.","volume":"11","author":"Song","year":"2021","journal-title":"J Glob Health"},{"issue":"12","key":"yoi260047r3","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1080\/14737175.2016.1204914","article-title":"ADHD in old age: a review of the literature and proposal for assessment and treatment.","volume":"16","author":"Kooij","year":"2016","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"yoi260047r4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/14737175.2024.2385932","article-title":"Why is ADHD so difficult to diagnose in older adults?","volume":"24","author":"Goodman","year":"2024","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"yoi260047r5","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1177\/1087054717714057","article-title":"Risk of dementia in adults with ADHD: a nationwide, population-based cohort study in Taiwan.","volume":"23","author":"Tzeng","year":"2019","journal-title":"J Atten Disord"},{"issue":"9","key":"yoi260047r6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S2215-0366(21)00171-1","article-title":"Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study.","volume":"8","author":"Du Rietz","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"yoi260047r7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1192\/j.eurpsy.2021.2261","article-title":"Attention-deficit\/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: a population-based register study.","volume":"65","author":"Dobrosavljevic","year":"2021","journal-title":"Eur Psychiatry"},{"issue":"10","key":"yoi260047r8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.38088","article-title":"Adult attention-deficit\/hyperactivity disorder and the risk of dementia.","volume":"6","author":"Levine","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"yoi260047r9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/acps.13694","article-title":"Somatic burden of attention-deficit\/hyperactivity disorder across the lifecourse.","volume":"150","author":"Libutzki","year":"2024","journal-title":"Acta Psychiatr Scand"},{"issue":"9","key":"yoi260047r10","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jagp.2024.04.005","article-title":"Adult attention deficit-hyperactivity disorder is associated with Lewy body disease and cognitive impairment: a prospective cohort study with 15-year follow-up.","volume":"32","author":"Golimstok","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"yoi260047r11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuint.2017.08.005","article-title":"Antecedent ADHD, dementia, and metabolic dysregulation: a U.S. based cohort analysis.","volume":"112","author":"Fluegge","year":"2018","journal-title":"Neurochem Int"},{"issue":"4","key":"yoi260047r12","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf281","article-title":"Association of neurodevelopmental conditions with Alzheimer\u2019s disease and related dementias and Parkinson\u2019s disease.","volume":"81","author":"Rast","year":"2025","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"yoi260047r13","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jaac.2021.01.019","article-title":"Systematic review: how the attention-deficit\/hyperactivity disorder polygenic risk score adds to our understanding of ADHD and associated traits.","volume":"60","author":"Ronald","year":"2021","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"yoi260047r14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41562-026-02475-8","article-title":"Polygenic risk scores are not genetic predispositions.","volume":"10","author":"Furrer","year":"2026","journal-title":"Nat Hum Behav"},{"issue":"3","key":"yoi260047r15","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/s41380-022-01867-2","article-title":"Genetic risk for attention-deficit\/hyperactivity disorder predicts cognitive decline and development of Alzheimer\u2019s disease pathophysiology in cognitively unimpaired older adults.","volume":"28","author":"Leffa","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi260047r16","doi-asserted-by":"publisher","DOI":"10.1162\/99608f92.cbe67e91","article-title":"Data quality in electronic health record research: an approach for validation and quantitative bias analysis for imperfectly ascertained health outcomes via diagnostic codes.","volume":"4","author":"Goldstein","year":"2022","journal-title":"Harv Data Sci Rev"},{"issue":"1","key":"yoi260047r17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087054718757648","article-title":"Self-reported ADHD and adult health in the United States.","volume":"25","author":"Landes","year":"2021","journal-title":"J Atten Disord"},{"issue":"4","key":"yoi260047r18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4088\/JCP.v67n0403","article-title":"Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community.","volume":"67","author":"Biederman","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"yoi260047r19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/00004583-200312000-00008","article-title":"Attention-deficit\/hyperactivity disorder: increased costs for patients and their families.","volume":"42","author":"Swensen","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"yoi260047r20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d research program.","volume":"381","author":"Denny","year":"2019","journal-title":"N Engl J Med"},{"issue":"8003","key":"yoi260047r21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program.","volume":"627","author":"Bick","year":"2024","journal-title":"Nature"},{"issue":"4","key":"yoi260047r22","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"yoi260047r23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s11689-022-09447-9","article-title":"An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities.","volume":"14","author":"Slaby","year":"2022","journal-title":"J Neurodev Disord"},{"issue":"2","key":"yoi260047r24","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains.","volume":"55","author":"Demontis","year":"2023","journal-title":"Nat Genet"},{"issue":"9","key":"yoi260047r25","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","article-title":"PRSice: polygenic risk score software.","volume":"31","author":"Euesden","year":"2015","journal-title":"Bioinformatics"},{"issue":"4","key":"yoi260047r26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/EDE.0000000000001028","article-title":"Development of the initial surveys for the All of Us Research Program.","volume":"30","author":"Cronin","year":"2019","journal-title":"Epidemiology"},{"issue":"5","key":"yoi260047r27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"23","key":"yoi260047r28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.21105\/joss.00648","article-title":"Comorbidity: an R package for computing comorbidity scores.","volume":"3","author":"Gasparini","year":"2018","journal-title":"J Open Source Softw"},{"key":"yoi260047r29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2147\/CLEP.S568699","article-title":"Discriminative ability of the Charlson Comorbidity Index for long-term mortality in a general population: nationwide, population-based study of 10 million adults in Sweden.","volume":"17","author":"Westerberg","year":"2025","journal-title":"Clin Epidemiol"},{"issue":"24","key":"yoi260047r30","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1002\/sim.2098","article-title":"Choice of time-scale in Cox\u2019s model analysis of epidemiologic cohort data: a simulation study.","volume":"23","author":"Thi\u00e9baut","year":"2004","journal-title":"Stat Med"},{"issue":"1","key":"yoi260047r32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/S0033291719003039","article-title":"The positive end of the polygenic score distribution for ADHD: a low risk or a protective factor?","volume":"51","author":"Li","year":"2021","journal-title":"Psychol Med"},{"key":"yoi260047r33","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1158546","article-title":"Risk of neurodegenerative disease or dementia in adults with attention-deficit\/hyperactivity disorder: a systematic review.","volume":"14","author":"Becker","year":"2023","journal-title":"Front Psychiatry"},{"key":"yoi260047r34","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.826213","article-title":"ADHD and neurodegenerative disease risk: a critical examination of the evidence.","volume":"13","author":"Becker","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"yoi260047r35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0321","article-title":"Racial disparities in diagnosis of attention-deficit\/hyperactivity disorder in a US national birth cohort.","volume":"4","author":"Shi","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"yoi260047r36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamapsychiatry.2020.2788","article-title":"Prevalence and risk factors associated with attention-deficit\/hyperactivity disorder among US Black individuals: a systematic review and meta-analysis.","volume":"78","author":"C\u00e9nat","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"yoi260047r37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease.","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"yoi260047r38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.38080","article-title":"Psychiatric disorders before and after dementia Diagnosis.","volume":"6","author":"Mo","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"yoi260047r39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12877-023-04601-x","article-title":"Comorbid health conditions and their impact on social isolation, loneliness, quality of life, and well-being in people with dementia: longitudinal findings from the IDEAL programme.","volume":"24","author":"Sabatini","year":"2024","journal-title":"BMC Geriatr"},{"issue":"8","key":"yoi260047r40","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1093\/brain\/awaa209","article-title":"Genetic variants and functional pathways associated with resilience to Alzheimer\u2019s disease.","volume":"143","author":"Dumitrescu","year":"2020","journal-title":"Brain"},{"issue":"2","key":"yoi260047r41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/jamapsychiatry.2013.277","article-title":"Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit\/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.","volume":"70","author":"Hart","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"yoi260047r42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/arclin\/acx055","article-title":"The neurocognitive profile of attention-deficit\/hyperactivity disorder: a review of meta-analyses.","volume":"33","author":"Pievsky","year":"2018","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"yoi260047r43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-024-00495-0","article-title":"Attention-deficit\/hyperactivity disorder.","volume":"10","author":"Faraone","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"yoi260047r44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder.","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"yoi260047r45","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jaac.2021.05.019","article-title":"Review: adult outcome as seen through controlled prospective follow-up studies of children with attention-deficit\/hyperactivity disorder followed into adulthood.","volume":"61","author":"Cherkasova","year":"2022","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"yoi260047r46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105313","article-title":"Genetic architecture of ADHD and overlap with other psychiatric disorders and cognition-related phenotypes.","volume":"153","author":"Ribas\u00e9s","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"yoi260047r47","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","article-title":"Duration of preclinical, prodromal, and dementia stages of Alzheimer\u2019s disease in relation to age, sex, and APOE genotype.","volume":"15","author":"Vermunt","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"4","key":"yoi260047r48","doi-asserted-by":"publisher","first-page":"e421","DOI":"10.4088\/JCP.14m09630","article-title":"Gender differences in adult attention-deficit\/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).","volume":"77","author":"Cortese","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"yoi260047r49","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s11136-011-9981-9","article-title":"ADHD burden of illness in older adults: a life course perspective.","volume":"21","author":"Brod","year":"2012","journal-title":"Qual Life Res"},{"issue":"4","key":"yoi260047r50","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1192\/bjp.bp.111.101196","article-title":"Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands.","volume":"201","author":"Michielsen","year":"2012","journal-title":"Br J Psychiatry"},{"key":"yoi260047r31","unstructured":"Yang? D, Dalton? JE. A unified approach to measuring the effect size between two groups using SAS. Published 2012. Accessed September 1, 2026. https:\/\/www.semanticscholar.org\/paper\/A-unified-approach-to-measuring-the-effect-size-two-Yang-Dalton\/6cf4bd36ca4c90006a5d6563f646a391c255581b"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2854889\/jamapsychiatry_bauernegrini_2026_oi_260047_1791577816.11595.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:00:19Z","timestamp":1791579619000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2854889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":50,"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2026.3165","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,7]]}}}